SAG
ANGO icon

SageView Advisory Group’s AngioDynamics ANGO Stock Holding History

SageView Advisory Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$720 Buy
+56
New +$691 ﹤0.01% 2406

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KK
Kotler Kevin $427M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SageView Advisory Group's ANGO Position: Q4 2025 in Review

SageView Advisory Group opened a new position in AngioDynamics (ANGO) in Q4 2025: 56 shares worth $720. The stake represents ﹤0.01% of the portfolio and ranks #2406 among its holdings.

167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

  • SageView Advisory Group held 56 shares of AngioDynamics worth $720 as of Q4 2025.
  • AngioDynamics was a new SageView Advisory Group position in Q4 2025.
  • AngioDynamics made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2406 holding.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.